Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
zfVUE8YdhgTupwH1
Français